Growth Metrics

Eli Lilly (LLY) EBT (2009 - 2026)

Eli Lilly posted quarterly EBT of $8.9 billion for Q1 2026, up 156.08% year-on-year from $3.5 billion in Q1 2025, and up 7.06% on a QoQ basis from $8.3 billion in Q4 2025.

Eli Lilly (LLY) has 18 years of EBT data on file, last reported at $8.9 billion in Q1 2026.

  • For the quarter ending Q1 2026, EBT rose 156.08% year-over-year to $8.9 billion; the trailing twelve-month figure through Mar 2026 stood at $31.1 billion (up 128.86% YoY), and the FY2025 full-year result was $25.7 billion, up 102.93% from the prior year.
  • EBT for Q1 2026 stood at $8.9 billion, up from $8.3 billion in the prior quarter.
  • Across five years, EBT topped out at $8.9 billion in Q1 2026 and bottomed at $427.2 million in Q3 2023.
  • The 5-year median for EBT is $2.5 billion (2023), against an average of $3.6 billion.
  • The widest annual swing landed in 2023, when EBT slumped 72.71%; it then soared 355.33% in 2025.
  • A 5-year view of EBT shows it stood at $2.1 billion in 2022, then gained by 19.64% to $2.5 billion in 2023, then soared by 100.87% to $5.0 billion in 2024, then soared by 64.07% to $8.3 billion in 2025, then increased by 7.06% to $8.9 billion in 2026.
  • The last three EBT figures came in at $8.9 billion (Q1 2026), $8.3 billion (Q4 2025), and $7.2 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 8.85 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 5.99 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 1.04 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -3.50 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 2.08 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 2.58 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 3.17 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 3.24 Bn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8.85 Bn
Dec 31, 2025 8.27 Bn
Sep 30, 2025 7.23 Bn
Jun 30, 2025 6.78 Bn
Mar 31, 2025 3.46 Bn
Dec 31, 2024 5.04 Bn
Sep 30, 2024 1.59 Bn
Jun 30, 2024 3.52 Bn
Mar 31, 2024 2.54 Bn
Dec 31, 2023 2.51 Bn
Sep 30, 2023 427.20 Mn
Jun 30, 2023 2.09 Bn
Mar 31, 2023 1.53 Bn
Dec 31, 2022 2.10 Bn
Sep 30, 2022 1.57 Bn
Jun 30, 2022 1.09 Bn
Mar 31, 2022 2.05 Bn
Dec 31, 2021 1.84 Bn
Sep 30, 2021 1.25 Bn
Jun 30, 2021 1.59 Bn
Mar 31, 2021 1.48 Bn
Dec 31, 2020 2.47 Bn
Sep 30, 2020 1.44 Bn
Jun 30, 2020 1.64 Bn
Mar 31, 2020 1.68 Bn
Dec 31, 2019 1.66 Bn
Sep 30, 2019 1.41 Bn
Jun 30, 2019 1.47 Bn
Mar 31, 2019 731.10 Mn
Dec 31, 2018 931.60 Mn
Sep 30, 2018 1.34 Bn
Jun 30, 2018 41.70 Mn
Mar 31, 2018 1.37 Bn
Dec 31, 2017 391.50 Mn
Sep 30, 2017 591.60 Mn
Jun 30, 2017 1.26 Bn
Mar 31, 2017 61.20 Mn
Dec 31, 2016 892.00 Mn
Sep 30, 2016 970.70 Mn
Jun 30, 2016 944.50 Mn
Mar 31, 2016 566.80 Mn
Dec 31, 2015 444.60 Mn
Sep 30, 2015 1.05 Bn
Jun 30, 2015 679.70 Mn
Mar 31, 2015 617.90 Mn
Dec 31, 2014 513.60 Mn
Sep 30, 2014 655.50 Mn
Jun 30, 2014 940.40 Mn
Mar 31, 2014 890.80 Mn
Dec 31, 2013 909.90 Mn
Sep 30, 2013 1.51 Bn
Jun 30, 2013 1.51 Bn
Mar 31, 2013 1.95 Bn
Dec 31, 2012 1.01 Bn
Sep 30, 2012 1.87 Bn
Jun 30, 2012 1.19 Bn
Mar 31, 2012 1.34 Bn
Dec 31, 2011 1.04 Bn
Sep 30, 2011 1.50 Bn
Jun 30, 2011 1.53 Bn
Mar 31, 2011 1.27 Bn
Dec 31, 2010 1.41 Bn
Sep 30, 2010 1.67 Bn
Jun 30, 2010 1.74 Bn
Mar 31, 2010 1.71 Bn
Dec 31, 2009 1.14 Bn
Sep 30, 2009 1.07 Bn
Jun 30, 2009 1.47 Bn
Mar 31, 2009 1.68 Bn